Navigation Links
Weight-loss surgery can cut cancer risk
Date:6/19/2008

This release is available in French.

Montreal, 19 June 2008 Successful bariatric surgery allows morbidly obese patients to lose up to 70 percent of their excess weight and to maintain weight loss. The latest study by Dr. Nicolas Christou of the McGill University Health Centre (MUHC) and McGill University shows that this surgery also decreases the risk of developing cancer by up to 80 percent. Dr. Christou presented his preliminary results yesterday at the 25th Annual Meeting of the American Society for Metabolic & Bariatric Surgery.

The researchers compared 1,035 morbidly obese patients who underwent bariatric surgery at the MUHC between 1986 and 2002 with 5,746 patients with the same weight profile who did not undergo the operation. The number of cancer diagnoses in first group was 85 percent lower for breast cancer and 70 percent lower for colon and pancreatic cancers, and was also distinctly lower for several other types of cancer.

"The relationship between obesity and many forms of cancer is well established," said Dr. Christou. "This is one of the first studies to suggest that bariatric surgery might prevent the risk of cancer for a significant percentage of morbidly obese people."

Obesity affects the body in multiple ways, so a single hypothesis cannot fully explain these results, say the researchers. However, excess body fat is widely thought to be responsible for increased hormone production, a major risk factor for breast and colon cancer. Thus so modifications to the patient's hormonal metabolism due to weight loss might explain the lower incidence of these cancers in patients who underwent surgery.

"Bariatric surgery is an extremely efficient tool in the treatment of morbid obesity and its consequences, and the MUHC is one of Canada's leaders in this field." Dr. Christou said. "We're hoping that these results will help the government and public health authorities realize the importance of this procedure in the fight against the various pathologies associated with obesity."


'/>"/>

Contact: Isabelle Kling
isabelle.kling@muhc.mcgill.ca
514-843-1560
McGill University Health Centre
Source:Eurekalert

Related biology news :

1. Study: weight-loss tips differ in African-American, mainstream magazines
2. Research examines factors in delaying or declining total knee replacement surgery
3. New surgery improves head and neck cancer treatment
4. Craniosynostosis minimally invasive surgery holds more promise than old procedure
5. Pennsylvania Hospital recognized for excellence in bariatric surgery
6. Listen-up ladies: Dont postpone knee-replacement surgery
7. Surgery without stitches
8. BMI criteria for obesity surgery should be lowered, UT Southwestern researcher suggests
9. Pennsylvania Hospital surgeon receives grant to develop molecular cardiac surgery
10. Minimally invasive heart surgery research wins NIH award
11. Urologists identify 7 biomarkers that may help pinpoint prostate cancer recurrence
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2016)... LONDON , April 26, 2016 /PRNewswire/ ... Systems, a product subsidiary of Infosys (NYSE: ... partnership to integrate the Onegini mobile security platform ... http://photos.prnewswire.com/prnh/20151104/283829LOGO ) The integration ... security to access and transact across channels. Using ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
(Date:3/31/2016)... -- Genomics firm Nabsys has completed a financial  restructuring under ... M.D., who returned to the company in October 2015. ... including Chief Technology Officer, John Oliver , Ph.D., ... Vice President of Software and Informatics, Michael Kaiser ... Bready served as CEO of Nabsys from 2005-2014 and ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... ... 2016 , ... Charm Sciences, Inc. is pleased to announce ... Research Institute approval 061601. , “This is another AOAC-RI approval of the Peel ... President of Regulatory and Industrial Affairs. “The Peel Plate methods perform comparably to ...
(Date:6/23/2016)... SAN FRANCISCO , June 23, 2016   ... it has secured $1 million in debt financing from ... to ramp up automation and to advance its drug ... for its new facility. "SVB has been ... goes beyond the services a traditional bank would provide," ...
(Date:6/23/2016)... ... 2016 , ... In a new case report published today in STEM CELLS ... developed lymphedema after being treated for breast cancer benefitted from an injection of stem ... with this debilitating, frequent side effect of cancer treatment. , Lymphedema refers ...
Breaking Biology Technology: